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[Background] Since most genes are expressed in more than one tissue
and engaged in many functions, some genetic variant could be
associated with unpredicted diseases with or without interactions with
other genetic variants or environmental factors. Recently Pembrey
and Jones proposed a new method, ‘phenome scan’ (analogous to
‘genome-wide scan’, but in an opposite direction), in which dense
phenotypic information in human cohorts is scanned for associations
with individual genetic variants. We attempted to apply this method
to our comprehensive clinicopathological database derived from large
numbers of autopsy cases. [Subjects] The subjects of this database
derived from more than 2,000 consecutive autopsies from the patients
died in a community-based geriatric general hospital during recent 12
years. Most of the cases were registered in a SNP database named
‘A Database of Japanese Single Nucleotide Polymorphism for Geri-
atric Research (JG-SNP)’ and freely accessible on the Internet at
http://www.tmgh.metro.tokyo.jp/jg-snp/english/E_top.html. [Results]
The average age of the patients was 80 years and male to female ratio
was 1.2. The autopsy rate has declined from 46 to 21% during this
period. The database contained patient information, histories of
smoking and drinking, clinical diagnosis including 26 geriatric dis-
eases, serum lipid data, 750 pathological findings, 42 major
pathological diagnoses, atherosclerotic degrees of 10 major arteries,
emphysematous degrees, and so on. Twenty-six geriatric diseases
included 6 cardiovascular diseases, 3 neurological diseases, 5 meta-
bolic and skeletal disease, 3 respiratory diseases, 4 malignancies and
so on. Forty-two major pathological diagnoses included an extended
and partially overlapping list of geriatric diseases. Both clinical and
subclinical findings were registered among 750 pathological findings.
DNA was extracted from unfixed renal tissue in all cases and used for
molecular analysis. The results of application of this method to sev-
eral genes such as CAR, NOS3 and PRKCH will be presented.
[Conclusions] In contrast to physiological limitation of human gen-
ome (3 gigabase), human phenome is unlimited and difficult to define.
Although the number of the subjects registered in this database and
available medical information were limited, this database was still
useful for the phenome scan to identify significant associations
between genetic variant, especially for the genes of unknown func-
tions, and geriatric diseases or pathological conditions.
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Background and aim: FAP is an autosomal dominantly inherited form
of colorectal cancer caused by a germline mutation in the adenoma-
tous polyposis coli (APC) gene. We search for new cancer gene in
a subgroup of APC mutation-negative FAP variant patients with
autosomal dominant inheritance and typical adenomatous polyps
(100s–1000) but have accelerated disease progression. Methods: We
performed Whole Genome Sampling Assay on both the lymphocyte
and polyp DNA of two affected individuals of a FAP variant family
and lymphocyte DNA of 2 other affected, 4 unaffected members and
18 ethnicity-matched healthy controls using Affymetrix Genome-
Wide Human single nucleotide polymorphism (SNP) Array 5.0. This
SNP Array 5.0 enables genotyping of approximately 450 K SNPs and
assaying of an additional 500 K non-polymorphic copy number (CN)
probes, covering the entire genome with an average inter-probe dis-
tance of *10 kb. Results: By using the Copy Number Tool of Partek
Genomic Suite Software, a 40 kb region consisting of 17 CN but no
SNP probes showed gain of copy number in germline of all four
affected members (mean CN = 4.20) compared to the four unaffected
members as baseline. We are currently verifying this copy number
gain and investigating the expression of a putative oncogene 18 kb
downstream. Further, a 111 kb region on another chromosome, con-
sisting of 44 CN probes, showed copy number loss in all eight polyp
DNAs (mean CN = 0.68) compared to the matched lymphocyte DNAs
of two affected individuals. Fragments chosen randomly from this
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critical region for PCR analysis further confirmed the copy number
loss. Data mining with NCBI Build 36.2, however, reveal no known
gene but only one putative 2.2 kb transcript in melanoma tissue.
Extensive RT-PCR analysis indicated that this transcript is probably
non-existent in lymphocyte and colonic mucosa tissues. Conclusion:
Structural variations may contribute to polyposis in FAP variant
patients without detectable APC germline mutation.
060: Modelling potential CNV effects on human fertility
by manipulating meiosis in mice
Howard J. Cooke, Evelina Bolcun-Filas, Robert Speed, Mary
Taggart
MRC Human Genetics Unit and Institute of Genetics and Molecular
Medicine, Western General Hospital, Edinburgh, United Kingdom
Male and female fertility requires completion of meiosis to produce
the haploid gametes. Meiosis is a complex process in which the two
genomes in the diploid cell have to be aligned with single base pair
accuracy and linked by crossover events to ensure correct segregation
at the cell divisions needed to produce haploid cells. In humans fer-
tility is highly variable and a substantial part of that variation is
genetic. The phenotype is hard to measure and involves input from
two individuals making whole genome association studies difficult if
not impossible. Candidate gene approaches based on a knowledge of
the underlying processes of gametogenesis have had limited success.
This is a reflection of the large number of genes thought to be
required, particularly for sperm production, and since the majority of
mutations are likely to be recessive, homozygosity at any one locus
for such a mutation is likely to be rare. It is possible that more
common processes such as copy number variation may be involved.
The level of proteins in the cell may be critical of function especially
when forming structural complexes with multiple other proteins. We
have asked if compound heterozygosity at genes encoding proteins
required for meiosis can affect the process. SYCE1 and SYCE2 are
proteins of the meiotic Synaptonemal Complex. We have shown that
SYCE2 is essential for male and female fertility in mice and here we
show that this is also true for SYCE1. Heterozygous null animals are
fertile in the case of both genes. Male mice heterozygous for both null
alleles are also fertile but have an increased rate of XY asynapsis and
reduced sperm count showing that compound hemizygosity in genes
involved in the same pathway can have a significant impact. Since
these proteins form a complex with others to generate the Synapto-
nemal Complex without which cross-overs can not complete it is
likely that the defects we observe result from changes in protein
levels. Copy number variation could result in similar effects in human
populations.
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Frontotemporal lobar degeneration (FTLD) is a neurodegenerative
brain disorder with a prevalence similar to that of Alzheimer’s disease
in the population below age 65 years. In some patients FTLD
symptoms are accompanied by signs of motor neuron disease (MND).
A positive family history is observed in up to 50% of FTLD patients
indicating a significant contribution of genetics to the etiology of
FTLD. A high degree of genetic heterogeneity has been observed with
different mutations in the genes encoding the microtubule-associated
protein (MAPT), progranulin (PGRN), charged multivesicular body
protein 2B (CHMP2B) and valosin containing protein (VCP). Further,
two loci on chromosome 9 at 9q21–q22 and 9p13–21 were implicated
in FTLD with MND (FTLD-MND). In Belgian familial FTLD
patients 65% remained unexplained by mutations in known FTLD
genes. Of one patient diagnosed with FTLD-MND, we collected DNA
of relatives and performed a genome-wide scan. We identified and
finemapped a novel chromosomal locus that was not previously linked
to FTLD and/or MND. Haplotype analysis identified a risk haplotype
of 23 cM that co-segregated with disease. Further reduction of the
candidate region and mutation analyses of positional and functional
candidate genes are ongoing. Identification of the mutation in the
underlying disease gene will significantly contribute to the under-
standing of neurodegenerative disease mechanisms in FTLD.
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Submicroscopic copy number variants (CNVs) identified by array
genome hybridization (AGH) are now known to cause mental retar-
dation (MR) as frequently as cytogenetically detectable genetic
defects. We screened 100 trios each comprising a child with idio-
pathic MR and both normal parents using Affymetrix 500 K
GeneChip Human mapping assays and detected causative de novo
CNVs in 16 cases. Two patients carried overlapping deletions of
9p11.2p13.3; one a *11 Mb deletion from 33.7 to 44.7 Mb, and the
other a *4.6 Mb deletion from 34.1 to 38.7 Mb. The distal non-
overlapping portion (from 38.7 to 44.7 Mb) is highly enriched in low
copy repeat (LCR) elements and poorly assayed by Affymetrix 500 K
SNP probes. We re-screened both patients using Affymetrix 6.0
GeneChips which have greater than threefold higher coverage of the
region and include non-SNP probes which show more robust per-
formance for regions involved in LCR. On this platform we found the
single deletion in the first case to be composed of two smaller dele-
tions (a *6 Mb deletion from 33.4 to 39.3 Mb and a 0.7 Mb deletion
from 44.1 to 44.8 Mb) as well as an additional small deletion (of
0.6 Mb from 44.2 to 44.8 Mb) in the second patient previously
undetected. Choosing the appropriate platform is important when
assaying genomic regions involved in complex genomic architecture.
We found a *10.8 Mb deletion of 7p15.3 in another patient. Our
patient’s CNV overlaps with five other deletion and duplication CNVs
reported in the DECIPHER database, suggesting the identification of
a novel region that is prone to disease causing variation. A 6.9 Mb
duplication of 8q12.1 in another case involves the CHD7 gene, which
causes CHARGE syndrome when deleted. This patient’s phenotypes
include defects in organ systems (cardiac, ocular, auditory and gen-
ital) affected in CHARGE syndrome. In another patient we identified
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a rare whole chromosome uni-parental disomy (UPD) for chromo-
some 16 that we believe is pathogenic. This heterodisomic UPD
would not have been detected by a non-SNP probe AGH platform.
We also screened patients who were normal on Affymetrix 100 K
GeneChip AGH with the higher resolution 500 K platform and
detected causative CNVs in two patients. A 4p16.3 deletion in a
patient subsequently diagnosed with mild Wolf-Hirschorn syndrome
and a novel 1.5 Mb duplication of 8q22.3 in another case. These data
highlight the usefulness of higher resolution AGH and demonstrate
the varying benefits of different probe sets.
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Mental retardation (MR) affects 1–3% of live births and has both
genetic and non-genetic causes. A proportion of cases with genetic
abnormalities are attributable to mutations of genes on the X chro-
mosome. Although many X-linked MR (XLMR) genes have been
reported, identification of more by conventional approaches has
become problematic. To address this, we have implemented a strategy
in which the coding exons of 719 X chromosome genes have been
systematically resequenced for disease-causing variants in 206
XLMR families. This approach has yielded at least 10 new XLMR
genes with several more to be validated. Many families still remain to
be explained. The study has revealed the pattern of haplotypic coding
sequence variation on the X chromosome and indicates that loss of
function of *1% of X chromosome genes is compatible with
apparently normal existence. This work has also highlighted issues
that may be faced in the future by whole genome screens for rare
disease-causing variants in other complex phenotypes.
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